Home
Contact Us
Site Map
Home
> Investors
Investors
News Releases
5/8/2008
King Pharmaceuticals Reports First-Quarter 2008 Financial Results
4/24/2008
King Pharmaceuticals and Acura Pharmaceuticals Announce Completion of Patient Enrollment For Pivotal Phase III Clinical Trial Evaluating Acurox™
4/9/2008
King Pharmaceuticals Announces Date for Release of First Quarter 2008 Earnings
3/31/2008
King Pharmaceuticals Presents Positive Results Of Corvue™ Phase III Clinical Trials At The American College Of Cardiology (ACC) Annual Scientific Conference
2/28/2008
King Pharmaceuticals Reports Year-End And Fourth-Quarter 2007 Financial Results
read more »
Recent Web Casts
5/8/2008 11:00 AM EST
king pharmaceuticals first quarter financial results and strategy
Home
About Us
Products
Investors
Business Development
Careers
Community
Contact Us
Site Map
Legal
©2000-2008 King Pharmaceuticals,
®
Inc. All rights reserved.
About Us
Vision
Who We Are
Why Choose King?
Strategy
Fast Facts
Products
Avinza® CII
Skelaxin®
Thrombin-JMI®
Altace®
Sonata® CIV
Levoxyl®
Meridian Auto injector Products/EpiPen®
Alphabetic Listing of Products
NDC Listing of Products
Authorized Distributors of Record
Investors
News Releases
Annual Report
SEC Documents
SEC Section 16 Reports
Governance
Webcasts
Business Development
Careers
Job Search
Benefits
Culture and Diversity
Why Choose King?
Locations
Community
News Releases
Annual Report
SEC Documents
SEC Section 16 Reports
Governance
Webcasts